India's first vaccine against cervical cancer!!!
Cervical cancer is the second largest cancer in women. In such a situation, the Serum Institute of india has developed the first indigenous vaccine against it. The vaccine was sent to the DCGI for approval.
The vaccine may be launched this year
The application to the DCGI refers to the antibody response of the vaccine against HPV types in all dosages and age groups. According to sources, the vaccine is expected to be launched on the market before the end of 2022.
The second test also successful
qHPV is India's first indigenously developed vaccine against cervical cancer. To ensure its early availability in the country, the Pune-based Serum Institute of india has applied for market authorization after completing Phase II testing with the support of the Department of Biotechnology.
What is cervical cancer?
Cervical cancer is cancer of the mouth of the uterus. According to the World health Organization WHO, cervical cancer is the fourth most common cancer in women in the world and according to the assessment, 6,04,000 new cases of this cancer were reported in the year 2020 and 3,42,000 women died due to this.
Generally, the symptoms of this cancer are not visible in the early stages, and only when the disease has spread enough, its symptoms start showing. If the vaccine is approved, then it could prove to be a revolutionary step toward the treatment of cancer in women.
Cervical cancer vaccine imported from other countries
So far in india, cervical cancer vaccine is imported from other countries. Under the government Vaccine Program, this vaccine is not available for free. Due to its import from other countries, its price is also very high and its reach in small towns and villages is very limited. The Modi government is considering including the cervical vaccine in the vaccination program as part of the plan to expand health programs.
